Neuroglia is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2021. The journal covers Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system.
Authors are required to pay an article processing charge to publish in Neuroglia; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Neuroglia has published 157 articles. Articles are minted with DOIs through the prefix 10.3390. All submissions undergo plagiarism screening before peer review.
Keywords
function and pathology of glia, glial functions in development, disease and injuries, potential therapies for humans, glial cells, nervous system
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2021
- Review time
- 6 weeks
- DOI prefix
10.3390- Plagiarism check
- Yes
ISSN
- electronic
- 2571-6980
Frequently asked questions
Is Neuroglia peer-reviewed?
Does Neuroglia charge an article processing charge (APC)?
What subjects does Neuroglia publish?
What languages does Neuroglia accept?
What is the ISSN of Neuroglia?
2571-6980 (electronic).